Sandy Spring Bank Abbott Laboratories Transaction History

Sandy Spring Bank

$2.4 Billion
Q3 2024

A detailed history of Sandy Spring Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Sandy Spring Bank holds 110,003 shares of ABT stock, worth $13 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

110,003

Previous 119,785 8.17%

Holding current value

$13 Million

Previous $12.4 Million 0.76%

% of portfolio

0.52%

Previous 0.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $978,884 - $1.16 Million	-9,782 Reduced 8.17%	110,003 $12.5 Million
Q2 2024 Aug 06, 2024	SELL	$100.73 - $112.44 $802,112 - $895,359	-7,963 Reduced 6.23%	119,785 $12.4 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $2.16 Million - $2.39 Million	-19,735 Reduced 13.38%	127,748 $14.5 Million
Q4 2023 Jan 26, 2024	SELL	$90.19 - $110.4 $616,629 - $754,804	-6,837 Reduced 4.43%	147,483 $16.2 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $279,616 - $335,492	-2,927 Reduced 1.86%	154,320 $14.9 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $186,140 - $207,399	-1,847 Reduced 1.16%	157,247 $17.1 Million
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $675,598 - $795,219	-6,975 Reduced 4.2%	159,094 $16.1 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $40,970 - $48,065	-431 Reduced 0.26%	166,069 $18.2 Million
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $241,029 - $279,066	-2,491 Reduced 1.47%	166,500 $16.1 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $451,761 - $546,035	-4,426 Reduced 2.55%	168,991 $18.4 Million
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $341,261 - $416,146	2,993 Added 1.76%	173,417 $20.5 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $179,418 - $219,687	1,553 Added 0.92%	170,424 $24 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $251,868 - $278,640	-2,159 Reduced 1.26%	168,871 $19.9 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $458,811 - $540,086	4,337 Added 2.6%	171,030 $19.8 Million
Q1 2021 May 03, 2021	BUY	$108.84 - $128.23 $15,564 - $18,336	143 Added 0.09%	166,693 $20 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $167,265 - $182,271	1,593 Added 0.97%	166,550 $18.2 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $350,431 - $425,572	3,824 Added 2.37%	164,957 $18 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $479,940 - $614,264	6,268 Added 4.05%	161,133 $14.7 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $306,435 - $448,093	4,878 Added 3.25%	154,865 $12.2 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $299,986 - $333,955	3,821 Added 2.61%	149,987 $13 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $314,183 - $340,672	3,839 Added 2.7%	146,166 $12.2 Million
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $342,025 - $398,905	4,693 Added 3.41%	142,327 $12 Million
Q1 2019 May 06, 2019	BUY	$66.22 - $80.06 $237,200 - $286,774	3,582 Added 2.67%	137,634 $11 Million
Q4 2018 Feb 08, 2019	SELL	$65.56 - $74.27 $262,371 - $297,228	-4,002 Reduced 2.9%	134,052 $9.7 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $238,557 - $287,791	3,923 Added 2.92%	138,054 $10.1 Million
Q2 2018 Aug 03, 2018	BUY	$57.57 - $63.54 $41,738 - $46,066	725 Added 0.54%	134,131 $8.18 Million
Q1 2018 May 04, 2018	BUY	$56.27 - $63.62 $149,903 - $169,483	2,664 Added 2.04%	133,406 $7.99 Million
Q4 2017 Feb 02, 2018	BUY	$53.68 - $57.47 $189,114 - $202,466	3,523 Added 2.77%	130,742 $7.46 Million
Q3 2017 Nov 03, 2017	SELL	$48.06 - $53.64 $92,707 - $103,471	-1,929 Reduced 1.49%	127,219 $6.79 Million
Q2 2017 Aug 11, 2017	BUY	N/A	129,148	129,148 $6.31 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.

Account

Sandy Spring Bank Abbott Laboratories Transaction History